With a disease as complex as chronic obstructive pulmonary disease (COPD), identifying the risk of onset is incredibly difficult. While traditional risk factors, such as smoking, are primary indicators, new emerging risk factors are becoming more clear.
The findings of the recent MESA Lung Study and SPIROMICS analysis determined that genetic lung variants play a significant role in identifying COPD risk. This is pivotal information in helping transform the way we think about COPD, help implement preventative measures, diagnose it, and potentially even treat it.
The good news is—you can test for genetic lung variants through a low-dose CT scan. This will help identify any concerns in a manner that inflicts the least harm to the patient.
While these new insights are extremely valuable, the question is: how can you use them today to detect COPD risk earlier? Read on for our insider tips on how to put this information into practice and leverage it to drive health.